IPO Boutique

Galera Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Galera Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Galera Therapeutics, Inc.GRTX -
NASDAQ
$14.00-$16.00 $12.00 $12.505 million11/7/2019
BofA Merrill Lynch, Citigroup, Credit Suisse
Co-Manager(s):
BTIG
Health Care
Filing(s):

Filed 2019-10-11
Terms Added 2019-10-28



Galera Therapeutics, Inc. Quote & Chart - Click for current quote - GRTX

About Galera Therapeutics, Inc. (adapted from Galera Therapeutics, Inc. prospectus):
They are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "GRTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved